Transduction of brain by herpes simplex virus vectors
- PMID: 17164771
- DOI: 10.1038/sj.mt.6300018
Transduction of brain by herpes simplex virus vectors
Abstract
An imposing obstacle to gene therapy is the inability to transduce all of the necessary cells in a target organ. This certainly applies to gene transfer to the brain, especially when one considers the challenges involved in scaling up transduction from animal models to use in the clinic. Non-neurotropic viral gene transfer vectors (e.g., adenovirus, adeno-associated virus, and lentivirus) do not spread very far in the nervous system, and consequently these vectors transduce brain regions mostly near the injection site in adult animals. This indicates that numerous, well-spaced injections would be required to achieve widespread transduction in a large brain with these vectors. In contrast, herpes simplex virus type 1 (HSV-1) is a promising vector for widespread gene transfer to the brain owing to the innate ability of the virus to spread through the nervous system and form latent infections in neurons that last for the lifetime of the infected individual. In this review, we summarize the published literature of the transduction patterns produced by attenuated HSV-1 vectors in small animals as a function of the injection site, and discuss the implications of the distribution for widespread gene transfer to the large animal brain.
Similar articles
-
In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.J Gene Med. 2004 Mar;6(3):288-99. doi: 10.1002/jgm.490. J Gene Med. 2004. PMID: 15026990
-
Gene delivery using herpes simplex virus vectors.DNA Cell Biol. 2002 Dec;21(12):915-36. doi: 10.1089/104454902762053864. DNA Cell Biol. 2002. PMID: 12573050 Review.
-
Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors.Hum Gene Ther. 1999 Oct 10;10(15):2481-94. doi: 10.1089/10430349950016825. Hum Gene Ther. 1999. PMID: 10543613
-
Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.J Virol. 2001 May;75(9):4343-56. doi: 10.1128/JVI.75.9.4343-4356.2001. J Virol. 2001. PMID: 11287583 Free PMC article.
-
The use of herpes simplex virus-based vectors for gene delivery to the nervous system.Mol Med Today. 1997 Sep;3(9):404-11. doi: 10.1016/S1357-4310(97)01106-4. Mol Med Today. 1997. PMID: 9302691 Review.
Cited by
-
Bilateral single-site intracerebral injection of a nonpathogenic herpes simplex virus-1 vector decreases anxiogenic behavior in MPS VII mice.Mol Ther Methods Clin Dev. 2015 Jan 28;2:14059. doi: 10.1038/mtm.2014.59. eCollection 2015. Mol Ther Methods Clin Dev. 2015. PMID: 26052529 Free PMC article.
-
Gene Therapy Tools for Brain Diseases.Front Pharmacol. 2019 Jul 1;10:724. doi: 10.3389/fphar.2019.00724. eCollection 2019. Front Pharmacol. 2019. PMID: 31312139 Free PMC article. Review.
-
Gene therapy for the nervous system: challenges and new strategies.Neurotherapeutics. 2014 Oct;11(4):817-39. doi: 10.1007/s13311-014-0299-5. Neurotherapeutics. 2014. PMID: 25159276 Free PMC article. Review.
-
Gene therapy in epilepsy.Epilepsia. 2009 Jan;50(1):24-32. doi: 10.1111/j.1528-1167.2008.01743.x. Epub 2008 Aug 19. Epilepsia. 2009. PMID: 18717707 Free PMC article. Review.
-
Antioxidant enzyme gene transfer for ischemic diseases.Adv Drug Deliv Rev. 2009 Apr 28;61(4):351-63. doi: 10.1016/j.addr.2009.01.005. Epub 2009 Feb 20. Adv Drug Deliv Rev. 2009. PMID: 19233238 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
